Brief: Biomaxima Signs 8.9 Mln Zloty Deal For Rapid Antigene SARS-CoV-2 Tests
13/12/2021 10:50
Dec 13 (Reuters) - BioMaxima SA BMX.WA :
* SAYS SIGNS TOTAL 8.9 MILLION ZLOTY DEAL TO DELIVER RAPID
ANTIGENE SARS-COV-2 TESTS
Source text for Eikon: ID:nEMc9fVM0a
Further company coverage: BMX.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on BioMaxima SA
See all newsBrief: Biomaxima H1 Net Profit 0.7 Million Zlotys
Brief: BioMaxima Unit Signs 4-Year Agreement With Botosani Hospital For Reagent Deliveries
Brief: Biomaxima Says Asakura Completes Share Acquisition Process For Co's Shares
Brief: Biomaxima Says Asakura Invites To Buy 800,000 Biomaxima Shares At 10.50 Zlotys/Share
Brief: Biomaxima Q1 Net Profit 0.3 Million Zlotys